Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Lupus ; 9(8): 622-31, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11035438

RESUMEN

The objectives were to provide estimates of the prevalence of autoantibody (Ab) directed to CD45 in lupus patients, identify the target autoantigen(s), and determine the ability of such reactivity to mediate neutralization of T lymphocytes. Sera from 64 patients were studied using 2 assays: Western blot and an ELISA with CD45 eluted from 3 cell lines as antigen (U937, Jurkat and Daudi). The role of carbohydrate specificity was investigated using enzyme digestion of blotted glycans, competition with sugars, and inhibition with lectins. Apoptosis was studied through annexin V binding, and cell cycle analysis using the propidium iodide method. AutoAb to CD45 were detected in 16/64 sera (25%) by Western blot, and 21/32 sera (66%) found positive in the ELISA. CD45 purified from Daudi cells was identified in the ELISA, but not in the blot. AutoAb were of the IgM and the IgG isotypes, but not specific for a particular cell type or CD45 isoform: 2 dominant specificities were recognized, one against p180, and another against high MW isoforms. Neuraminidase-induced enhancement of reactivity, together with the inhibitory effect of N-acetyl galactosamine and Dolichos diflorus lectin suggest that the epitopes are carbohydrates. AutoAb which were specific for activated CD4+T cells triggered the annexin V binding, and, in 2 of 4 cases, lymphocytes underwent apoptosis. In conclusion, carbohydrate conformational epitopes may be important as target antigens, and some CD45 autoAb have the capacity to neutralize activated T cells through anergy or apoptosis.


Asunto(s)
Autoanticuerpos/sangre , Autoanticuerpos/inmunología , Antígenos Comunes de Leucocito/inmunología , Lupus Eritematoso Sistémico/inmunología , Activación de Linfocitos , Linfocitos T/inmunología , Anticuerpos Monoclonales , Sitios de Unión de Anticuerpos , Linfoma de Burkitt , Ensayo de Inmunoadsorción Enzimática , Humanos , Células Jurkat , Lupus Eritematoso Sistémico/sangre , Valores de Referencia , Células Tumorales Cultivadas , Células U937
2.
Biol Reprod ; 63(1): 259-66, 2000 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10859267

RESUMEN

This study was conducted to determine if the cadmium-mediated inhibition of vitellogenesis observed in fish collected from contaminated areas or undergoing experimental exposure to cadmium correlated with modification in the transcriptional activity of the estrogen receptor. A recombinant yeast system expressing rainbow trout (Oncorhynchus mykiss) estradiol receptor or human estradiol receptor was used to evaluate the direct effect of cadmium exposure on estradiol receptor transcriptional activity. In recombinant yeast, cadmium reduced the estradiol-stimulated transcription of an estrogen-responsive reporter gene. In vitro-binding assays indicated that cadmium did not affect ligand binding to the receptor. Yeast one- and two-hybrid assays showed that estradiol-induced conformational changes and receptor dimerization were not affected by cadmium; conversely, DNA binding of the estradiol receptor to its cognate element was dramatically reduced in gel retardation assay. This study provides mechanistic data supporting the idea that cadmium is an important endocrine disrupter through a direct effect on estradiol receptor transcriptional activity and may affect a number of estrogen signaling pathways.


Asunto(s)
Cadmio/farmacología , Oncorhynchus mykiss/metabolismo , Receptores de Estrógenos/antagonistas & inhibidores , Animales , ADN/metabolismo , Dimerización , Estradiol/metabolismo , Furilfuramida/metabolismo , Humanos , Metales Pesados/farmacología , Oncorhynchus mykiss/genética , Receptores de Estradiol/antagonistas & inhibidores , Receptores de Estradiol/genética , Receptores de Estrógenos/genética , Receptores de Estrógenos/metabolismo , Proteínas Recombinantes/efectos de los fármacos , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Transcripción Genética , Vitelogeninas/efectos de los fármacos , Vitelogeninas/metabolismo , Levaduras/genética
3.
Sem Hop ; 57(25-28): 1217-20, 1981.
Artículo en Francés | MEDLINE | ID: mdl-6266042

RESUMEN

Seronegative systemic lupus erythematosus is defined as a SLE devoided of antinuclear factors as well as of LE cells when at least 4 out of the 14 ARA criteria are present. We describe herein two case reports and review previous literature concerning this topic. This kind of SLE is characterized by a high incidence of Raynaud's disease, photosensitivity, oral ulcerations, alopecia and perhaps less frequent kidney and central nervous system involvement. The hypotheses about the absence of ANF are discussed. The awareness of such a SLE ("devoided of ANF rather than" seronegative") is to be kept in mind from a chemical, therapeutic and pathophysiologic point of view.


Asunto(s)
Anticuerpos Antinucleares/análisis , Lupus Eritematoso Sistémico/inmunología , Adulto , Femenino , Humanos , Lupus Eritematoso Sistémico/diagnóstico , Lupus Eritematoso Sistémico/fisiopatología , Masculino , Pruebas Serológicas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...